Ferroptosis induction by engineered liposomes for enhanced tumor therapy

• Alireza Ghasempour,
• Mohammad Amin Tokallou,
• Mohammad Reza Naderi Allaf,
• Mohsen Moradi,
• Hamideh Dehghan,
• Mahsa Sedighi,
• Mohammad-Ali Shahbazi and
• Fahimeh Lavi Arab

Beilstein J. Nanotechnol. 2025, 16, 1325–1349, doi:10.3762/bjnano.16.97

• the localized and controlled delivery of medicine [108]. Liposome–nanoparticle hybrids integrate the benefits of both liposomes and nanoparticles. These hybrids provide a synergistic approach to treating complicated diseases like cancer by enabling multimodal medicines, such as combining chemotherapy

• with photothermal or photodynamic therapy. These hybrids are especially promising in cancer therapy. For instance, theranostic liposome–nanoparticle hybrids integrate therapeutic agents with imaging capabilities, allowing for simultaneous treatment and real-time tumor response monitoring [136

Small protein sequences can induce cellular uptake of complex nanohybrids

• Jan-Philip Merkl,
• Malak Safi,
• Christian Schmidtke,
• Fadi Aldeek,
• Johannes Ostermann,
• Tatiana Domitrovic,
• Sebastian Gärtner,
• John E. Johnson,
• Horst Weller and
• Hedi Mattoussi

Beilstein J. Nanotechnol. 2019, 10, 2477–2482, doi:10.3762/bjnano.10.238

• on the ability of functional fusion proteins presenting a lytic gamma peptide, to promote interactions with HeLa cells and delivery of large hybrid nanostructures. Keywords: bioconjugation; cellular uptake; nanoparticle hybrids; polymer encapsulation; self-assembly; Introduction Developing hybrid